BRCA2 and breast carcinoma: Deleterious BRCA2 mutations have been observed in 4 to up to 14% of male breast cancers [27–31], whereas BRCA 1 mutations are rare, except in individuals of Ashkenazi Jewish ethnicity [30, 31].